.AstraZeneca has actually shared an early check out the performance of its internal antibody-drug co...
.After announcing a stage 3 launch based upon favorable midstage end results, iTeos and also GSK are...
.The FDA ought to be actually even more open and also collective to let loose a rise in approvals of...
.It is actually an extraordinarily active Friday for biotech IPOs, along with Zenas BioPharma, MBX a...
.Atea Pharmaceuticals' antiviral has neglected another COVID-19 trial, however the biotech still kee...
.Neurocrine Biosciences' schizophrenia course pivot has neglected. The biotech was unable to reprodu...
.Sanofi has brought in a late entry to the radioligand celebration, paying 100 thousand euros ($ 110...
.After F2G's 1st try to get a brand-new course of antifungal to market was hindered by the FDA, the ...
.Moderna has sworn to cut R&D investing through $1.1 billion by 2027. The decision to shrink the ...
.Merely 4 months after Sanofi wager $80 million in upfront cash on Key Rehabs' losmapimod, the cours...